Antiangiogenic agents
US6995278B2 · kind B2 · utility
4Cited by
34References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 8, 2001 |
| Grant date | Feb 7, 2006 |
| Priority date | — |
| Expiry date | Feb 8, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07J1/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compositions and methods for treating mammalian disease characterized by undesirable angiogenesis by administering derivatives of 2-methoxyestradiol of the general formula: wherein the variables are defined in the specification.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.